DERIVE POLYCYCLIQUE DE CINNAMIDE

«Composition pharmaceutique nouvelle» Il est révélé des compositions pharmaceutiques nouvelles contenant de l'acide 3'-[(2Z)-[1-(3,4-diméthylphényl)-1,5-dihydro-3-méthyl-5-oxo-4H-pyrazole-4-ylidène]hydrazino]-2'-hydroxy-[1,1'-biphényl]-3-carboxylique bis-(monoéthanolamine) (eltro...

Full description

Saved in:
Bibliographic Details
Main Authors MIYAGAWA, TAKEHIKO, DOI, ERIKO, KIMURA, TEIJI, SATO, NOBUAKI, KANEKO, TOSHIHIKO, KAWANO, KOKI, DOKO, TAKASHI, ITO, KOICHI, TAKAISHI, MAMORU, HAGIWARA, HIROAKI, KITAZAWA, NORITAKA, SASAKI, TAKEO
Format Patent
LanguageFrench
Published 02.03.2009
Edition7
Online AccessGet full text

Cover

Loading…
More Information
Summary:«Composition pharmaceutique nouvelle» Il est révélé des compositions pharmaceutiques nouvelles contenant de l'acide 3'-[(2Z)-[1-(3,4-diméthylphényl)-1,5-dihydro-3-méthyl-5-oxo-4H-pyrazole-4-ylidène]hydrazino]-2'-hydroxy-[1,1'-biphényl]-3-carboxylique bis-(monoéthanolamine) (eltrombopag olamine) et des procédés pour leur préparation. Disclosed is a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar 1 represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like, Ar 2 represents a phenyl group which may be substituted by a C1-6 alkoxy group, or the like, X 1 represents a double bond or the like, and Het represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like. The compound or the salt is effective as a therapeutic or prophylactic agent for a disease associated with A².
Bibliography:Application Number: MA20080031220